PERFECT MEDICAL (01830) announced that it expects shareholder profit attributable for the six months ending September 30, 2025, to range between HKD 93 million and HKD 98 million, compared to HKD 141 million recorded in the same period ending September 30, 2024. However, the projected shareholder profit for the current period is expected to show an increase of no less than 40% compared to the approximately HKD 66 million recorded in the second half of the 2025 fiscal year.